High-Cost Chronic Claims Underscore Importance of Early Detection
In its 2025 High-Cost Claims and Injectable Drug Trend Analysis, Sun Life highlights a familiar but costly trend: malignant neoplasm (cancer) and cardiovascular disease continue to rank among the top drivers of stop-loss claim reimbursements. These chronic conditions...
Cutting Specialty Drug Costs Without Cutting Access
Specialty medications continue to drive a disproportionate share of prescription drug costs – often accounting for 60% or more of a pharmacy plan’s total spend. MedBen Rx’s Benefit Preservation helps plans manage these expenses without compromising care by...
Unwrapped: A Smarter Approach to Out-of-Network Pricing
Unexpected out-of-network charges can quietly reduce the savings of a self-funded health plan, especially when traditional wrap networks don’t always deliver consistent cost control. To address this, Unwrapped, offered in partnership with MedBen and The Phia Group,...
Is Your Team Using All the Benefits of MedBen Access Mobile?
Many of your plan members are still not taking advantage of the benefits of using the MedBen Access Mobile App, despite its convenience and time savings. Encouraging adoption can improve engagement, reduce benefit-related questions, and empower members to manage their...
Major PBMs Are Blocking Biosimilar Savings, but MedBen Rx Offers a Better Path
The advantages of biosimilars – clinically equivalent versions of high-price biologic drugs – have been known for years. But despite their growing availability, adoption remains slow... in no small part because major PBMs are stifling uptake. Fortunately,...
Maximum Savings, Minimum Noise: The MedBen Fair Market Pricing Advantage
When it comes to controlling plan costs, guessing isn’t a strategy – data is. MedBen offers a variety of alternative reimbursement options for groups that want to go beyond standard PPOs... among them, fair market pricing, which reviews every claim against national...
Health Care Benefits Remain the Top Priority for Employers
Health care continues to lead the pack when it comes to employee benefits, according to the 2025 SHRM Employee Benefits Survey. Nearly 9 in 10 employers say health-related benefits are “extremely” or “very” important to their workforce – outranking retirement savings...
Johns Hopkins Study Highlights Missed Opportunities in Cholesterol Care
A new study from Johns Hopkins Bloomberg School of Public Health reveals a missed opportunity in preventive care: Nearly half of U.S. adults eligible for cholesterol-lowering therapy aren’t receiving it. The analysis estimates that proper use of these medications...
Want Proven Solutions? Look No Further Than MedBen!
According to a recent national survey of over 1,800 U.S. employers, reducing health care costs has surpassed attracting and retaining talent as the top driver of benefits decision-making – a first since the survey began in 2019. Additionally, 53% of employers say they...
Dependent Care FSA Limit Increased for First Time in Nearly 40 Years
The recently enacted “One Big Beautiful Bill” Act (H.R. 1) includes a long-awaited update for working families: a permanent increase in the annual contribution limit for dependent care assistance flexible spending accounts (DCAPs). Beginning in tax years after...
High-Value Formulary Helps Members Resist the Pharma Ad Blitz
Pharmaceutical advertising hit a record high in 2024, with the top 10 drugs accounting for $3.3 billion in ad spending – up nearly 20% from the previous year. With more campaigns directly targeting consumers, MedBen Rx’s high-value formulary educates members about...
MedBen Clients Beat Rising Health Spending Trend
Per Fierce Healthcare: “A new report from federal actuaries estimates national health spending will increase by 7.1% in 2025, with spending growth set to outpace growth in the U.S. gross domestic product.” Historically, MedBen clients have maintained a cost trend...